Luis Rengifo
Luis Rengifo is a representative of Medifarma S.A., who is implicated in a preliminary investigation regarding the alleged production and distribution of defective saline solution linked to adverse health effects in patients.
Not in the pool (under ¢1).
Recent news mentions
Luis Rengifo followed with a single, which took May out of the game.
Cerveceros, sin hit en 7 innings, remontan en el octavo y vencen a los Cardenales
Dominican Republic· 2026-05-28
Luis Rengifo, de los Angelinos de Los Ángeles, compite por el premio al Guante de Oro.
quiénes son los venezolanos finalistas
Venezuela· 2025-10-16
Luis Rengifo was hit by a pitch from Caleb Boushley in the seventh inning.
Emotions hot in Angels victory
Taiwan· 2025-07-31
Luis Rengifo had a selection play but went 0-3 in the game.
Pete Alonso conecta jonrón de tres carreras y Mets barren a Angelinos, Juan Soto de 4-0Dominican Republic· 2025-07-25
Luis Rengifo went 3-0 with one run scored for the Angels.
Fernando Tatis Jr. decide para los Padres y deja a los Angelinos en el terrenoDominican Republic· 2025-05-14
Luis Rengifo scored a run for the Angels in the game.
Salvador Pérez firmó otra marca con los RealesVenezuela· 2025-04-11
Luis Rengifo produced one run.
Jackson Chourio logra el segundo juego de su carrera con varios jonronesVenezuela· 2025-04-07
Luis Rengifo contributed with a run and an RBI for the Angels.
Eugenio Suárez frenó a los Yankees con un Grand SlamVenezuela· 2025-04-02
Luis Rengifo is also under investigation for alleged falsification and adulteration of pharmaceutical products.
Medifarma: Minsa ordena cierre total del laboratorio tras fallas en suero fisiológico | Últimas | LIMA
Peru· 2025-03-31
Luis Rengifo had a 4-2 performance in the game.
José Soriano lanza en grande en la victoria de AnaheimDominican Republic· 2025-03-30
Luis Rengifo is also under investigation for his role in the alleged adulteration of products at Medifarma S.A.
Fiscalía inicia investigación a Medifarma S.A. por suero fisiológico defectuoso | últimas | LIMAPeru· 2025-03-30